METT10D expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.558550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.994000E-01
Normal-vs-Stage2
2.877600E-02
Normal-vs-Stage3
6.327800E-02
Normal-vs-Stage4
2.520000E-01
Stage1-vs-Stage2
3.100400E-01
Stage1-vs-Stage3
1.880750E-01
Stage1-vs-Stage4
3.778600E-01
Stage2-vs-Stage3
2.379800E-01
Stage2-vs-Stage4
7.444400E-01
Stage3-vs-Stage4
1.994370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.803770E-01
Normal-vs-AfricanAmerican
5.725200E-01
Normal-vs-Asian
1.209590E-02
Caucasian-vs-AfricanAmerican
4.630300E-02
Caucasian-vs-Asian
4.016300E-02
AfricanAmerican-vs-Asian
3.742700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.141800E-02
Normal-vs-Female
2.759600E-01
Male-vs-Female
2.512200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.879200E-01
Normal-vs-Age(41-60Yrs)
3.592800E-01
Normal-vs-Age(61-80Yrs)
4.751900E-02
Normal-vs-Age(81-100Yrs)
2.248200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.468800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.546400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.325400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.619500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.058400E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.104400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.684700E-03
Normal-vs-Daily Drinker
1.500200E-01
Normal-vs-Weekly Drinker
5.960400E-02
Normal-vs-Occasional Drinker
1.448950E-01
Normal-vs-Social Drinker
6.596800E-01
Non Drinker-vs-Daily Drinker
3.640000E-01
Non Drinker-vs-Weekly Drinker
3.658400E-01
Non Drinker-vs-Occasional Drinker
5.575600E-02
Non Drinker-vs-Social Drinker
8.186100E-02
Daily Drinker-vs-Weekly Drinker
8.939600E-01
Daily Drinker-vs-Occasional Drinker
5.813400E-01
Daily Drinker-vs-Social Drinker
2.133800E-01
Weekly Drinker-vs-Occasional Drinker
4.476200E-01
Weekly Drinker-vs-Social Drinker
2.032200E-01
Occasional Drinker-vs-Social Drinker
4.100000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.089000E-01
Normal-vs-Grade 2
9.759200E-01
Normal-vs-Grade 3
9.925800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.248100E-02
Grade 1-vs-Grade 3
4.484000E-02
Grade 1-vs-Grade 4
6.089000E-01
Grade 2-vs-Grade 3
7.517800E-01
Grade 2-vs-Grade 4
9.759200E-01
Grade 3-vs-Grade 4
9.925800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.743600E-03
Normal-vs-NonDiabetic
2.394800E-01
Diabetic-vs-NonDiabetic
4.879800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.681160E-01
Normal-vs-NoPancreatitis
1.465640E-01
Pancreatitis-vs-NoPancreatitis
8.672800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.299800E-01
Normal-vs-N1
3.119500E-02
N0-vs-N1
1.890190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.902000E-03
Normal-vs-TP53-NonMutant
6.320400E-01
TP53-Mutant-vs-TP53-NonMutant
6.45169999999862E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
